The typical case for the fund is to invest in rounds with 5 participants. Despite the Perceptive Life Sciences, startups are often financed by Third Rock Ventures, Sanofi, Cowen Group. The meaningful sponsors for the fund in investment in the same round are Cowen Group, Cormorant Asset Management, Casdin Capital.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2015. The high activity for fund was in 2015.
We can highlight the next thriving fund investment areas, such as Alternative Medicine, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight MyoKardia. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| Background Capital | - |
| BOHE Angel Fund | China, Jiangsu, Suzhou |
| Computer Software Association of Japan | Chiyoda, Japan |
| Good Technology | California, Sunnyvale, United States |
| GPB Capital Holdings | New York, New York, United States |
| Humboldt Innovation | Berlin, Berlin, Germany |
| L Capital Partners | New York, New York, United States |
| Maritime Blue Innovation Accelerator | New York, New York, United States |
| Mitacs | British Columbia, Canada, Vancouver |
| NKC ASIA | Japan, Tokyo |
| OTS | Aichi Prefecture, Japan, Kasugai |
| Rambus | California, Los Altos, United States |
| Software Innovation | Akershus, Lysaker, Norway |
| STARTegy Ventures | Coahuila, Mexico, Monclova |
| Wing | - |
| zkValidator | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kindbody | $26M | 06 Sep 2022 | New York, New York, United States | ||
ALOHA | 01 Nov 2017 | Connecticut, United States | |||
MyoKardia | $46M | 30 Apr 2015 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kindbody | $26M | 06 Sep 2022 | New York, New York, United States | ||
ALOHA | 01 Nov 2017 | Connecticut, United States | |||
MyoKardia | $46M | 30 Apr 2015 | California, United States |
